Literature DB >> 8180609

Establishment and characterization of a human leukemic cell line (SR-91) with features suggestive of early hematopoietic progenitor cell origin.

H G Klingemann1, H J Gong, G Maki, D E Horsman, B I Dalal, G L Phillips.   

Abstract

The characterization of a cell line (designated SR-91) from a patient with clinical and morphological diagnosis of acute lymphoblastic leukemia (CD3-, CD2+, CD7+, germline TCR genes) who relapsed early after allogeneic bone marrow transplantation, is reported. The line was established from blood cells obtained at diagnosis and placed in suspension culture with medium conditioned by 5637 cells. SR-91 cells are negative for lymphoid surface markers (CD3-, CD2-, CD7-) but positive for markers indicative of myeloid progenitor cells, such as CD33 and CD34. It is likely that the conditioned medium has induced myeloid differentiation from a lymphohematopoietic progenitor cell. After establishment, cells proliferated in response to GM-CSF stimulation but they are not factor-dependent and do not produce GM-CSF. No proliferative response to IL-1, IL-2, IL-3, IL-4, IL-6 or M-CSF was observed. Cells were completely resistant to anti-proliferative effects of tumor necrosis factor-alpha and interferon-alpha or -gamma, and showed no lysis after incubation with freshly isolated natural killer cells or IL-2-activated natural killer cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180609     DOI: 10.3109/10428199409073789

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.

Authors:  Laurent Boissel; Monica Betancur; Winfried S Wels; Hande Tuncer; Hans Klingemann
Journal:  Leuk Res       Date:  2009-01-14       Impact factor: 3.156

2.  Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.

Authors:  Matthew F Pech; Linda E Fong; Jacqueline E Villalta; Leanne Jg Chan; Samir Kharbanda; Jonathon J O'Brien; Fiona E McAllister; Ari J Firestone; Calvin H Jan; Jeffrey Settleman
Journal:  Elife       Date:  2019-08-27       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.